enGene Holdings announced that Ron Cooper has joined the company as CEO and member of the Board of Directors, effective July 22. This transition follows a previously announced succession plan for Jason Hanson, who will remain in service to the company as a strategic advisor. The company also announces Dr. Raj Pruthi’s promotion to Chief Medical Officer. Cooper most recently served as President and CEO of Albireo Pharma, a fully integrated global commercial biopharmaceutical company that Ipsen acquired in 2023.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENGN: